SCHEMBL4499459

SCHEMBL4499459

COC(=O)Nc1ccc(C(Nc2ccc(N(CCCN(C)C)C(C)=O)cc2)=C2C(=O)Nc3cc(F)ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.36
BACE1 P56817 1/20 0.36
TGM2 P21980 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PDGFRB P09619 2/20 0.33
NAMPT P43490 2/20 0.33
KDR P35968 2/20 0.33
PRKAA1 Q13131 2/20 0.33
CDK9 P50750 2/20 0.33
CHEK1 O14757 1/20 0.33
DAPK3 O43293 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33
PAK4 O96013 1/20 0.33
ABL1 P00519 1/20 0.33
LCK P06239 1/20 0.33
RET P07949 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4499455 1.00 FLT3 (0.36) FLT3BACE1TGM2KDM4EALDH1A1
SCHEMBL4490548 0.95 BACE1 (0.37) FLT3BACE1TGM2KDM4EALDH1A1
SCHEMBL4490543 0.95 BACE1 (0.37) FLT3BACE1TGM2KDM4EALDH1A1
SCHEMBL4499092 0.91 BACE1 (0.39) FLT3BACE1TGM2KDM4EPDGFRB
SCHEMBL4499093 0.91 BACE1 (0.39) FLT3BACE1TGM2KDM4EPDGFRB
SCHEMBL3526935 0.91 CHEK1 (0.35) FLT3BACE1TGM2KDM4EALDH1A1
SCHEMBL3526939 0.91 CHEK1 (0.35) FLT3BACE1TGM2KDM4EALDH1A1
SCHEMBL4497740 0.90 NPC1 (0.35) FLT3ALDH1A1PDGFRBKDRPRKAA1
SCHEMBL4497737 0.90 NPC1 (0.35) FLT3ALDH1A1PDGFRBKDRPRKAA1
SCHEMBL225427 0.89 BACE1 (0.35) FLT3BACE1TGM2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR FLT3 34/4885BACE1 1615/4885TGM2 4379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.